The buyer’s journey is the sequence of stages a prospective customer moves through from initial awareness of a problem or solution to a purchase decision and beyond. Organizations that map their sales and marketing activities to the buyer’s journey meet buyers where they are. Organizations that don’t push information at buyers regardless of where they are in the decision process and wonder why conversion rates are low.
The Stages
|
|
|
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Why the Sequence Matters Commercially
The buyer’s journey defines what information is useful at each stage. Content appropriate at the Evaluate stage — detailed technical specifications, comparative performance data, ROI models — is premature and alienating at the Aware or Discover stage.
Marketing’s role is to move buyers through Aware, Discover, and Interest with content that educates and builds preference. Sales’ role is to engage at Evaluate and Buy with conversations that address specific objections and facilitate the decision. The handoff should be defined by buyer behavior, not an arbitrary lead scoring threshold.
The Life Sciences Buyer Journey Is Not Linear
In life sciences purchasing, multiple stakeholders are involved at different stages. The scientist who identifies the need is not the procurement officer who approves the spend, who is not the quality leader who validates the supplier, who is not the operations manager who will live with the implementation. Each has their own journey, their own information needs, and their own objections.
Buyer journey mapping in life sciences requires persona-level specificity, not just stage-level awareness. The content, conversation, and commercial approach for each stakeholder must be developed deliberately and sequenced to account for how the internal purchase decision actually unfolds.